Select Medical (SEM) Reports In-Line Q3 EPS

Select Medical (NYSE: SEM) reported Q3 EPS of $0.20, in-line with the analyst estimate of $0.20. Revenue for the quarter came in at $758.1 million versus the consensus estimate of $750 million.

For earnings history and earnings-related data on Select Medical (SEM) click here.

You May Also Be Interested In

• McDonald’s said to plan value strategy overhaul to revive US sales growth
• Deutsche Bank Reiterates Buy Rating on Redcare Pharmacy NV (RDC:GR)
• Halozyme prices $1.3B convertible notes offering due 2033